Importantly, the expression of SLC1A5, SLC25A5, and ALDH1A1 was validated using circulating EVs from the plasma of an orthogonal sample set of 40 different TKI NSCLC patients compared with 20 healthy donors. This evidence concerns the gene SLC1A5 and non-small cell lung carcinoma.